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SES Superior to PES in Diabetics
Lee and colleagues compared the effectiveness of sirolimus-eluting stents (SES) andpaclitaxel-eluting stents (PES) in patients with diabetes. A total of 400 patients
were randomized to either PES or SES with a primary end point of in-segment
restenosis at 6 months. The relative risk of the primary end point was 0.19 for those
randomized to SES; similar reductions were found for in-stent restenosis and 9-month
target vessel revascularization. These results suggest that in diabetic patients, SES are
superior to PES. See page 727.
Page 737
Antiplatelet Therapy
Dual Nonresponders at High Risk for Stent Thrombosis
There is limited data on either the prevalence or clinical significance of resistance toboth clopidogrel and aspirin. Gori and colleagues assessed platelet reactivity to
measure resistance to clopidogrel and to aspirin. The incidence of dual nonresponsive-
ness was 6%, while nonresponsiveness to clopidogrel or aspirin was found in 6% and
11.5%, respectively. Definite/probable stent thrombosis was 5 times more likely in
dual nonresponders (11%) than in patients with resistance to either one alone or with
no resistance. Nonresponsiveness to both aspirin and clopidogrel occurs in about 1 in
20 patients and identifies patients at very high risk for stent thrombosis. See page
734. See figure.
Page 753
Heart Failure
Serum Levels of ACE2 Correlate With HF Severity
Angiotensin-converting enzyme 2 (ACE2) is a recently discovered homologue ofthe more widely known angiotensin-converting enzyme that antagonizes the
effects of angiotensin II and may be protective in animal heart failure (HF) models.
Epelman and colleagues measured serum activity of ACE2 (sACE2) in patients with
suspectedHF. sACE2activity correlatedwithB-typenatriuretic peptide levels, ejection
fraction, and New York Heart Association functional class. These results show that
sACE2 activity is increased in patientswithHFand suggest that sACE2maybe a target
for modulation. See page 750. See figure.
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Increased Heat Production in Stenotic Aortic Valve Leaflets
Toutouzas and colleagues hypothesized that heat production in the leaflets wouldcorrelatewith inflammationandneoangiogenesis inpatientswithaortic valve stenosis
(AVS). The temperature of the aortic valve leaflets and the aortic wall weremeasured in 25
patients undergoing aortic valve surgery.Thedifference in temperature between the leaflets
and the wall (T)was higher in patients with AVS than in those with aortic insufficiency,
andTcorrelatedwith the degree of inflammation and vascular endothelial growth factor
expression. These finding support the hypothesis that an active inflammatory process is
involved in the progression of AVS. See page 758.
